Viewing Study NCT07475234


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-04-05 @ 11:28 PM
Study NCT ID: NCT07475234
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-16
First Post: 2026-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor: Xiuchao Wang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module